Basic aspects of ketamine therapy for treatment-resistant depression - a review paper
Quality in Sport July 28, 2024 Weronika Szafrańska, Dominika Poborowska, Tomasz Gańko et al.
Introduction and purpose: Major depressive disorder (MDD) is the most common psychiatric illness, affecting millions of people worldwide. The first line of pharmacological treatment is usually monoamine reuptake inhibitors. Up to 60% of cases, may be drug-resistant patients, prompting researchers to research substances other than conventional. 1 The purpose of this article was to review recent...